Association of low-density lipoprotein cholesterol - Related genetic variants with aortic valve calcium and incident aortic stenosis

JAMA - Journal of the American Medical Association

Volumn 312, Issue 17, 2014, Pages 1764-1771

  Smith, J Gustav ^a,b,c,d,f   Luk, Kevin ^e   Schulz, Christina Alexandra ^c   Engert, James C ^e   Do, Ron ^a   Hindy, George ^c   Rukh, Gull ^c   Dufresne, Line ^e   Almgren, Peter ^c   Owens, David S ^g   Harris, Tamara B ^h   Peloso, Gina M ^d   Kerr, Kathleen F ^g   Wong, Quenna ^g   Smith, Albert V ^i,j   Budoff, Matthew J ^k   Rotter, Jerome I ^k   Cupples, L Adrienne ^l,m   Rich, Stephen ⁿ   Kathiresan, Sekar ^d,f,o   Orho Melander, Marju ^c,d   Gudnason, Vilmundur ^i,j   O'Donnell, Christopher J ^f,l,m,o,p   Post, Wendy S ^q   Thanassoulis, George ^e   more..

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h NATIONAL INSTITUTE ON AGING   (United States)

ⁱ ICELANDIC HEART ASSOCIATION   (Iceland)

^j UNIVERSITY OF ICELAND   (Iceland)

^k LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^l BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^m FRAMINGHAM HEART STUDY   (United States)

ⁿ UNIVERSITY OF VIRGINIA   (United States)

^o MASSACHUSETTS GENERAL HOSPITAL   (United States)

^p NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^q JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CALCIUM;

ADULT; AGED; AORTA VALVE CALCIUM; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK SCORE; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PREVALENCE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STUDY DESIGN; TRIACYLGLYCEROL BLOOD LEVEL; AORTA VALVE; AORTIC VALVE STENOSIS; ATHEROSCLEROSIS; BLOOD; CHEMISTRY; EPIDEMIOLOGY; GENETICS; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; RISK FACTOR; UNITED STATES;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; ATHEROSCLEROSIS; CALCIUM; CAUSALITY; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UNITED STATES;

EID: 84908689210     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.13959     Document Type: Article

References (32)

1. Go AS, Mozaffarian D, Roger V.L., et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2013 update: a report from the American Heart Association. Circulation. 2013; 127(1):e6-e245.
2. Iung B, Baron G, Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24(13): 1231-1243.
3. Stewart BF, Siscovick D, Lind B.K., et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997; 29(3):630-634.
4. Thanassoulis G, Campbell CY, Owens D.S., et al; CHARGE Extracoronary Calcium Working Group. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013; 368(6):503-512.
5. Cowell SJ, Newby DE, Prescott R.J., et al; Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005; 352(23):2389-2397.
6. Rossebø AB, Pedersen TR, Boman K, et al; SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008; 359(13):1343-1356.
7. Chan KL, Teo K, Dumesnil J.G., Ni A., Tam J; ASTRONOMER Investigators. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010; 121(2):306-314.
8. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R., Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 2009; 301(22):2331-2339.
9. Tikkanen E, Tuovinen T, Widén E, et al. Association of known loci with lipid levels among children and prediction of dyslipidemia in adults. Circ Cardiovasc Genet. 2011; 4(6):673-680.
10. Do R, Willer CJ, Schmidt E.M., et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013; 45 (11):1345-1352.
11. Psaty BM, O'Donnell CJ, Gudnason V, et al; CHARGE Consortium. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009; 2(1):73-80.
12. Smith JG, Platonov PG, Hedblad B, Engström G, Melander O. Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010; 25(2): 95-102.
13. Teslovich TM, Musunuru K, Smith A.V., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010; 466(7307):707-713.
14. Willer CJ, Schmidt EM, Sengupta S, et al; Global Lipids Genetics Consortium. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013; 45(11):1274-1283.
15. PLINK: whole genome association analysis toolset. http://pngu.mgh.harvard.edu/~purcell/plink/. Accessed October 6, 2014.
16. rproject.org. http://cran.rproject.org/web/packages/gtx/index.html. Accessed October 6, 2014.
17. Ehret GB, Munroe PB, Rice K.M., et al; International Consortium for Blood Pressure Genome-Wide Association Studies; CARDIoGRAM Consortium; CKDGen Consortium; KidneyGen Consortium; EchoGen Consortium; CHARGE-HF Consortium. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011; 478 (7367):103-109.
18. Burgess S, Butterworth A, Thompson SG Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-665.
19. Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. 2013; 178(7):1177-1184.
20. Cosmi JE, Kort S, Tunick P.A., et al. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch Intern Med. 2002; 162(20):2345-2347.
21. Coffey S, Cox B, Williams MJA. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol. 2014; 63(25 pt A):2852-2861.
22. Rajamannan NM, Edwards WD, Spelsberg TC Hypercholesterolemic aortic-valve disease. N Engl J Med. 2003; 349(7):717-718.
23. Thanassoulis G, Massaro JM, Cury R, et al Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium. J Am Coll Cardiol. 2010; 55(22):2491-2498.
24. Owens DS, Katz R, Johnson E., et al. Interaction of age with lipoproteins as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2008; 168(11): 1200-1207.
25. Rosenhek R, Rader F, Loho N., et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004; 110 (10):1291-1295.
26. Mundy G, Garrett R, Harris S., et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999; 286(5446):1946-1949.
27. O'Brien K.D., Reichenbach DD, Marcovina S.M., Kuusisto J., Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol. 1996; 16(4):523-532.
28. Otto CM, Kuusisto J, Reichenbach D.D., Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis: histological and immunohistochemical studies. Circulation. 1994; 90(2):844-853.
29. Hirsch D, Azoury R, Sarig S., Kruth HS. Colocalization of cholesterol and hydroxyapatite in human atherosclerotic lesions. Calcif Tissue Int. 1993; 52(2):94-98.
30. Parhami F, Morrow AD, Balucan J, et al Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: a possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997; 17(4):680-687.
31. Miller JD, Weiss RM, Serrano K.M., et al. Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. Circulation. 2009; 119(20): 2693-2701.
32. VanderWeele TJ, Tchetgen Tchetgen EJ, Cornelis M, Kraft P. Methodological challenges in Mendelian randomization. Epidemiology. 2014; 25 (3):427-435.